HomepageI1SR34 • BVMF
add
Intuitive Surgical
Vorige slotkoers
R$ 160,80
Jaar-range
R$ 75,17 - R$ 161,60
Beurswaarde
193,86 mld. USD
Gem. volume
2,54K
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 2,04 mld. | 16,88% |
Bedrijfskosten | 796,60 mln. | 13,57% |
Netto inkomsten | 565,10 mln. | 35,94% |
Netto winstmarge | 27,73 | 16,32% |
Winst per aandeel | 1,84 | 26,03% |
EBITDA | 693,50 mln. | 20,73% |
Effectief belastingtarief | 14,96% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 4,23 mld. | -34,65% |
Totale activa | 17,74 mld. | 20,60% |
Totale passiva | 2,07 mld. | -1,12% |
Totaal aandelenvermogen | 15,68 mld. | — |
Uitstaande aandelen | 356,18 mln. | — |
Koers-boekwaardeverhouding | 3,68 | — |
Rendement op activa | 8,39% | — |
Rendement op kapitaal | 9,47% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 565,10 mln. | 35,94% |
Operationele kasstroom | 706,50 mln. | 28,83% |
Kasstroom uit beleggingen | -1,41 mld. | -216,39% |
Kasstroom uit financiering | 98,20 mln. | 58,90% |
Nettomutatie in liquide middelen | -620,50 mln. | -475,38% |
Vrije kasstroom | 516,81 mln. | 105,39% |
Over
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.
Intuitive Surgical made its debut on the Fortune 500 list in 2024, ranking #497. Wikipedia
Opgericht
1995
Hoofdvestiging
Website
Werknemers
13.676